DNA-methylation age and accelerated epigenetic aging in blood as a tumor marker for predicting breast cancer susceptibility

By sjmartinez • December 8, 2024

Jung SY, Yu H, Deng Y, Pellegrini M. DNA-methylation age and accelerated epigenetic aging in blood as a tumor marker for predicting breast cancer susceptibility. Aging (Albany NY). 2024 Dec 5;16. doi: 10.18632/aging.206169. Epub ahead of print. PMID: 39642870.

Tags: breast cancer, Dermatology, DNA methylation-based marker of aging, Postmenopausal women, pre-diagnostic DNA, Publications, tumorigenesis

Use of ancillary studies in pediatric spitzoid neoplasms: A retrospective cohort study

Chen A, Krenitsky A, Perry SS, Tan KW, Swick BL, Anderson KR, Barry KK, Kelsey B, Carlberg VM, Coughlin CC, Craddock M, Fadzeyeva H, Ferringer[...]

Efficacy and Safety of Tildrakizumab for Treatment of Moderate-to-Severe Scalp Psoriasis in Patients with Obesity Over 52 Weeks

Sofen HL, Gogineni R, Nishandar T, Bagel J. Efficacy and Safety of Tildrakizumab for Treatment of Moderate-to-Severe Scalp Psoriasis in Patients with Obesity Over 52[...]

Ethical Considerations of Omitting Genital Examination During Skin Cancer Screening

Chou P, Lee K, Grant-Kels JM, Farshchian M. Ethical Considerations of Omitting Genital Examination During Skin Cancer Screening. J Am Acad Dermatol. 2026 Apr 28:S0190-9622(26)02571-5.[...]